OXY
46
-2
MET
50
3
ETN
83
4
MLM
72
2
CAH
40
-3
KR
55
2
PAYX
47
6
HBAN
56
2
HSIC
47
2
MDT
60
4
NVDA
63
4
APH
73
2
PRU
54
7
SHW
53
-6
INTC
35
3
SWK
55
3
AAP
33
4
UNH
46
-10
DNB
36
4
MSI
57
13
OXY
46
-2
MET
50
3
ETN
83
4
MLM
72
2
CAH
40
-3
KR
55
2
PAYX
47
6
HBAN
56
2
HSIC
47
2
MDT
60
4
NVDA
63
4
APH
73
2
PRU
54
7
SHW
53
-6
INTC
35
3
SWK
55
3
AAP
33
4
UNH
46
-10
DNB
36
4
MSI
57
13
Financhill
Back

Sophia Genetics SA 10K Form

Buy
75

SOPH
Sophia Genetics SA

Last Price:
5.01
Seasonality Move:
-33.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SOPH News And Ratings

See the #1 stock for the next 7 days that we like better than SOPH

SOPH Financial Statistics

Sales & Book Value

Annual Sales: $62.37M
Cash Flow: $-13.54M
Price / Cash Flow: 0
Annual Sales: $2.32
Price / Book: 2.16

Profitability

EPS (TTM): -1.22000
Net Income (TTM): $-78.98M
Gross Margin: $42.91M
Return on Equity: -45.57%
Return on Assets: -35.54%

Sophia Genetics SA Earnings Forecast

Key Sophia Genetics SA Financial Ratios

  • The Gross Profit Margin over the past 5 years for SOPH is 68.80%.
  • The Selling, General & Administrative Expenses for SOPH have been equal to 131.03% of Gross Profit Margin.
  • The Research & Development expenses have been 59.27% of Revenue.
  • The Interest Expense is -0.74% of Operating Income.
  • The Net Earning history of SOPH is -126.63% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Sophia Genetics SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: SOPH
Website: sophiagenetics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.16
Quick Ratio: 3.89

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SOPH Technical Analysis vs Fundamental Analysis

Buy
75
Sophia Genetics SA (SOPH) is a Buy

Is Sophia Genetics SA a Buy or a Sell?